SS
SHIMON STEIN
WEST FRONT STRATEGIES LLC · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
32
last 3 years
Filings
113
7 agencies contacted
Activity
filings by quarter
Works on
Health Issues 30Consumer Issues/Safety/Products 21Budget/Appropriations 19Copyright/Patent/Trademark 14Financial Institutions/Investments/Securities 12Pharmacy 10Taxation/Internal Revenue Code 10Medicare/Medicaid 9Telecommunications 8Labor Issues/Antitrust/Workplace 8Energy/Nuclear 7Communications/Broadcasting/Radio/TV 6Veterans 5Law Enforcement/Crime/Criminal Justice 5Waste (hazardous/solid/interstate/nuclear) 4Defense 4Retirement 4Trade (domestic/foreign) 4Travel/Tourism 4Aerospace 4Tobacco 4Small Business 2Education 1Agriculture 1
Background
Government experience
Senior Policy Advisor
House Majority Leader Eric Cantor; Program Manager, US Department of Justice; Legislative Correspondent, Senator John Ashcroft; Paid Intern, Represenative Robert Aderholt
Disclosed on LD-2 filings
Career
WF
Specific issues
Issues related to pharmacy, military pharmacies, pharmacist provider status, and Medicare reimbursement, including Equitable Community Access to Pharmacist Services Act (H.R. 1770 and S. 2477).
Monitor issues related to consumer data privacy.
Monitor issues related to ATSC 3.0 and artificial intelligence.
Monitor issues related to patent policy.
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023, S. 79 and HR 1717, and Medication Affordability and Patent Integrity Act, S.2780 and HR 5429; PREVAIL Act, S.2220 and HR 4370; Patent Eligibility Restoration Act of 2023, S.2140.
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503.
Clients
Filing history
RTX CORPORATION AND AFFILIATES
PRUDENTIAL FINANCIAL, INC.
ALLIANCE FOR SAFETY AND JUSTICE
THE PNC FINANCIAL SERVICES GROUP
CTIA - THE WIRELESS ASSOCIATION
THE CHICAGO SCHOOL OF PROFESSIONAL PSYCHOLOGY
AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. (FKA APA PRACTICE ORG.)
BROWN-FORMAN
T-MOBILE USA, INC.
VIATRIS INC
VELATURA PUBLIC BENEFIT CORPORATION
EXPEDIA, INC.